Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (3y) (2018 - 2026)
Insight Molecular Diagnostics (IMDX) Free Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 44.40% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -13.58% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 14.59% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 29.96% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -16.15% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 24.73% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 99.80% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -2.01% |
| 10 | Insight Molecular Diagnostics | 196.41 Mn | 167.48 Mn | 15,000.00 | 0.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.19% |
| Dec 31, 2025 | 12.40% |
| Sep 30, 2025 | 23.20% |
| Jun 30, 2025 | 18.69% |
| Mar 31, 2025 | 25.46% |
| Dec 31, 2024 | 9.33% |
| Sep 30, 2024 | 20.96% |
| Jun 30, 2024 | 10.72% |
| Mar 31, 2024 | 28.80% |
| Dec 31, 2023 | 9.43% |
| Sep 30, 2023 | 21.12% |
| Jun 30, 2023 | 2.85% |
| Mar 31, 2023 | -6.28% |
| Dec 31, 2022 | -18.97% |
| Sep 30, 2022 | -36.19% |
| Jun 30, 2022 | -63.08% |
| Mar 31, 2022 | -30.19% |
| Dec 31, 2021 | -44.86% |
| Sep 30, 2021 | -65.89% |
| Jun 30, 2021 | -29.69% |